Molecules 2011, 16(12), 10685-10694; doi:10.3390/molecules161210685
Article

Novel Pyrazolo[3,4-d]pyrimidine Derivatives as Potential Antitumor Agents: Exploratory Synthesis, Preliminary Structure-Activity Relationships, and in Vitro Biological Evaluation

Hai-Yun He 1,† , Jin-Ni Zhao 1,† , Ruo Jia 2,† , Ying-Lan Zhao 1 , Sheng-Yong Yang 1 , Luo-Ting Yu 1  and Li Yang 1,* email
1 State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medicinal School, Sichuan University, Chengdu 610041, Sichuan, China 2 College of Chemistry and Chemical Engineering, Chongqing University of Science and Technology, Chongqing 401331, China † These authors equally contributed to this work.
* Author to whom correspondence should be addressed.
Received: 20 November 2011; in revised form: 2 December 2011 / Accepted: 13 December 2011 / Published: 20 December 2011
(This article belongs to the Section Medicinal Chemistry)
PDF Full-text Download PDF Full-Text [364 KB, uploaded 20 December 2011 08:55 CET]
Abstract: In a cell-based screen of novel anticancer agents, the hit compound 1a which bears a pyrazolo[3,4-d]pyrimidine scaffold exhibited high inhibitory activity against a panel of four different types of tumor cell lines. In particular, the IC50 for A549 cells was 2.24 µM, compared with an IC50 of 9.20 µM for doxorubicin, the positive control. Four synthetic routes of the key intermediate 3 of 1a were explored and 1a was prepared via route D on the gram scale for further research. Two analogs of 1a were synthesized and their preliminary structure-activity relationships were studied. Flow cytometric analysis revealed that compound 1a could significantly induce apoptosis in A549 cells in vitro at low micromolar concentrations. These results suggest that the target compound 1a and its analogs with the pyrazolo[3,4-d]pyrimidine scaffold might potentially constitute a novel class of anticancer agents, which requires further studies.
Keywords: pyrazolo[3,4-d]pyrimidine; exploratory synthesis; anticancer activity; apoptosis

Article Statistics

Click here to load and display the download statistics.

Cite This Article

MDPI and ACS Style

He, H.-Y.; Zhao, J.-N.; Jia, R.; Zhao, Y.-L.; Yang, S.-Y.; Yu, L.-T.; Yang, L. Novel Pyrazolo[3,4-d]pyrimidine Derivatives as Potential Antitumor Agents: Exploratory Synthesis, Preliminary Structure-Activity Relationships, and in Vitro Biological Evaluation. Molecules 2011, 16, 10685-10694.

AMA Style

He H-Y, Zhao J-N, Jia R, Zhao Y-L, Yang S-Y, Yu L-T, Yang L. Novel Pyrazolo[3,4-d]pyrimidine Derivatives as Potential Antitumor Agents: Exploratory Synthesis, Preliminary Structure-Activity Relationships, and in Vitro Biological Evaluation. Molecules. 2011; 16(12):10685-10694.

Chicago/Turabian Style

He, Hai-Yun; Zhao, Jin-Ni; Jia, Ruo; Zhao, Ying-Lan; Yang, Sheng-Yong; Yu, Luo-Ting; Yang, Li. 2011. "Novel Pyrazolo[3,4-d]pyrimidine Derivatives as Potential Antitumor Agents: Exploratory Synthesis, Preliminary Structure-Activity Relationships, and in Vitro Biological Evaluation." Molecules 16, no. 12: 10685-10694.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert